TY - JOUR AU - Atkins, R. PY - 2005 DA - 2005// TI - The epidemiology of chronic kidney disease JO - Kidney Int Suppl VL - 67 UR - https://doi.org/10.1111/j.1523-1755.2005.09403.x DO - 10.1111/j.1523-1755.2005.09403.x ID - Atkins2005 ER - TY - JOUR AU - Robert, D. AU - Walter, H. H. PY - 2003 DA - 2003// TI - Anemia as a risk factor for the progression of chronic kidney disease JO - Curr Opin Nephrol Hypertens VL - 12 UR - https://doi.org/10.1097/00041552-200303000-00003 DO - 10.1097/00041552-200303000-00003 ID - Robert2003 ER - TY - JOUR AU - Donnelly, S. PY - 2001 DA - 2001// TI - Why is erythropoietin made in kidney? The kidney functions as a critmeter JO - Am J Kidney Dis VL - 38 UR - https://doi.org/10.1053/ajkd.2001.26111 DO - 10.1053/ajkd.2001.26111 ID - Donnelly2001 ER - TY - JOUR AU - National, K. F. PY - 2006 DA - 2006// TI - KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease JO - Am J Kidney Dis VL - 47 ID - National2006 ER - TY - JOUR AU - Bradbury, B. D. AU - Fissell, R. B. AU - Albert, J. M. AU - Anthony, M. S. AU - Critchlow, C. W. AU - Pisoni, R. L. PY - 2007 DA - 2007// TI - Predictors of early mortality among incident US hemodialysis patients in the Dialysis outcomes and practice patterns study (DOPPS) JO - Clin J Am Soc Nephrol VL - 2 UR - https://doi.org/10.2215/CJN.01170905 DO - 10.2215/CJN.01170905 ID - Bradbury2007 ER - TY - JOUR AU - Fernando, C. AU - Michel, B. PY - 2009 DA - 2009// TI - Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations JO - NDT Plus VL - 2 ID - Fernando2009 ER - TY - JOUR AU - Locatelli, F. AU - Pozzoni, P. AU - Vecchio, L. PY - 2007 DA - 2007// TI - Recombinant human epoetin beta in the treatment of renal anemia JO - Ther Clin Risk Manag VL - 3 ID - Locatelli2007 ER - TY - JOUR AU - Portolés, J. AU - Krisper, P. AU - Choukroun, G. AU - Francisco, A. L. PY - 2005 DA - 2005// TI - Exploring dosing frequency and administration routes in the treatment of anaemia in CKD patients JO - Nephrol Dial Transplant VL - 20 UR - https://doi.org/10.1093/ndt/gfh1111 DO - 10.1093/ndt/gfh1111 ID - Portolés2005 ER - TY - JOUR AU - Schmid, H. PY - 2014 DA - 2014// TI - Cost-effectiveness of continuous erythropoietin receptor activator in anemia JO - ClinicoEconomics and outcomes research: CEOR VL - 6 UR - https://doi.org/10.2147/CEOR.S46930 DO - 10.2147/CEOR.S46930 ID - Schmid2014 ER - TY - JOUR AU - Singh, A. K. AU - Szczech, L. AU - Tang, K. L. AU - Barnhart, H. AU - Sapp, S. AU - Wolfson, M. PY - 2006 DA - 2006// TI - CHOIR investigators. Correction of anemia with epoetin alfa in chronic kidney disease JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa065485 DO - 10.1056/NEJMoa065485 ID - Singh2006 ER - TY - JOUR PY - 2002 DA - 2002// TI - Darbepoetin alfa: a new erythropoietic drug for the treatment of renal anaemia JO - Nephrology VL - 7 UR - https://doi.org/10.1046/j.1440-1797.2002.00133.x DO - 10.1046/j.1440-1797.2002.00133.x ID - ref11 ER - TY - JOUR AU - Nissenson, A. R. AU - Swan, S. K. AU - Lindberg, J. S. PY - 2002 DA - 2002// TI - Randomized, controlled trial of darbepoetin for the treatment of anemia in hemodialysis patients JO - Am J Kidney Dis VL - 40 UR - https://doi.org/10.1053/ajkd.2002.33919 DO - 10.1053/ajkd.2002.33919 ID - Nissenson2002 ER - TY - STD TI - Mehta KS, Sinha SD, Bandi Vamsi, Bala Reddy, Naidu NR, Thakur PA, et al. Darbepoetin alfa versus erythropoietin alfa for treatment of renal anemia in patients with chronic kidney disease at the pre-dialysis stage: a randomized non-inferiority trial. J Assoc Physicians India. 2019;67:62–66. ID - ref13 ER -